Niki BioSolutions, Inc. (NIKI) Current Leases (2018 - 2025)

Niki BioSolutions' (NIKI) quarterly Current Leases came in at $38442.0 in Q4 2025, up 0.83% on a QoQ basis from $38126.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Current Leases (2018 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 8 years of Current Leases data on file, last reported at $38442.0 in Q4 2025.

Quarterly Current Leases changed N/A year-over-year to $38442.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $38442.0 (changed N/A YoY) and the FY2025 annual result came in at $24428.0, down 76.1% from the prior year.
Current Leases grew to $38442.0 in Q4 2025, from $38126.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $339649.0 in Q2 2022 to a low of $38126.0 in Q3 2025.
A 5-year average of $172304.4 and a median of $135311.5 in 2021 frame the typical range for Current Leases.
Annual changes were most pronounced in 2021 — Current Leases tumbled 66.39% — and 2022, when it jumped 113.6%.
Tracing NIKI's Current Leases over 5 years: stood at $145391.0 in 2021, then jumped by 113.6% to $310548.0 in 2022, then slumped by 59.67% to $125232.0 in 2023, then plunged by 67.92% to $40178.0 in 2024, then fell by 4.32% to $38442.0 in 2025.
The last three Current Leases figures came in at $38442.0 (Q4 2025), $38126.0 (Q3 2025), and $41383.0 (Q2 2025), per Business Quant data.

Download Data